This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bourgogne, A.
Right arrow Articles by Garsin, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bourgogne, A.
Right arrow Articles by Garsin, D. A.

 Previous Article  |  Next Article 

Journal of Bacteriology, September 2007, p. 6490-6493, Vol. 189, No. 17
0021-9193/07/$08.00+0     doi:10.1128/JB.00594-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

EbpR Is Important for Biofilm Formation by Activating Expression of the Endocarditis and Biofilm-Associated Pilus Operon (ebpABC) of Enterococcus faecalis OG1RF{triangledown}

Agathe Bourgogne,1,2 Kavindra V. Singh,1,2 Kristina A. Fox,3 Kathryn J. Pflughoeft,3 Barbara E. Murray,1,2,3* and Danielle A. Garsin2,3

Division of Infectious Diseases, Department of Medicine,1 Center for the Study of Emerging and Re-emerging Pathogens,2 Department of Microbiology and Molecular Genetics, University of Texas Medical School, Houston, Texas 770303

Received 17 April 2007/ Accepted 14 June 2007


arrow
ABSTRACT
 
We identify ef1090 (renamed ebpR) and show its importance for the transcriptional regulation of expression of the Enterococcus faecalis pilus operon, ebpABC. An ebpR deletion ({Delta}ebpR) mutant was found to have reduced ebpABC expression with loss of pilus production and a defect in primary adherence with, as a consequence, reduced biofilm formation.


arrow
TEXT
 
Enterococcus faecalis is a gram-positive bacterium that is part of the normal intestinal flora of most humans but is also a major cause of opportunistic infection (9). A major regulator of virulence in E. faecalis OG1RF is the Fsr system (15). In a previous microarray analysis, we identified several Fsr-regulated genes encoding putative regulators, one of which was ef1090 (2). EF1090 contains two putative helix-turn-helix DNA-binding domains and shares 42% similarity with AcpB from Bacillus anthracis, a member of the AtxA/MgaA family (4). Upstream and in the opposite orientation of ef1090 is the ebpABC operon, which encodes pilus components shown to be important for virulence in the rat endocarditis model and the mouse urinary tract infection model (13, 17).

To test whether the putative EF1090 regulator was involved in the regulation of the pili genes, we first performed semiquantitative reverse transcription-PCR (qRT-PCR) (2). The ebpA, ebpB, and ebpC transcripts were strongly reduced in an ef1090 transposon insertion mutant (5) compared to the parent strain (data not shown). Based on these results, ef1090 was renamed ebpR for its role as an endocarditis- and biofilm-associated pilus regulator. To prevent any effects caused by the transposon insertion from complicating our analysis, we then created an unmarked in-frame ebpR deletion mutant (Table 1) of OG1RF by using the recently published PheS* system (7). The {Delta}ebpR mutant had no growth defects compared to OG1RF in BHI, TSBG (biofilm medium), or BHI-40% horse serum (binding assay medium).


View this table:
[in this window]
[in a new window]

  		TABLE 1. Strains, plasmids, and primers used in this study

To assess transcriptional differences between OG1RF and the {Delta}ebpR mutant, we used microarray analysis with slide preparation (1), probe labeling, hybridization, data acquisition, and statistical analysis performed as described previously (2). RNA was extracted at late log growth phase from TSBG-grown cultures (2). Within the level of detection of the microarray analysis, the ebpABC transcript was undetectable in the {Delta}ebpR mutant compared to OG1RF, indicating that ebpR is important for ebpABC expression at the transcriptional level. srtC was not significantly altered in these conditions. We confirmed these results by using qRT-PCR (12). The amount of transcript for each gene of interest was normalized against gyrB transcripts. qRT-PCR showed that ebpA transcripts levels were decreased 119-fold (P = 0.0018) in the ebpR mutant versus the wild type, whereas srtC transcripts were only 1.7-fold decreased (P = 0.028) (Fig. 1A). The slight effect of ebpR on srtC is likely related to the presence of an independent srtC promoter and the low level of readthrough from the ebpA promoter described previously (13). Since basal ebpABC expression was detected in our ebpR mutant, our results indicate that ebpR, although important, is not essential for ebpABC expression.


Figure 1
View larger version (30K):
[in this window]
[in a new window]

  		FIG. 1. ebpA, srtC, and ebpR expression. (A) Real-time transcript levels of ebpA and srtC in OG1RF and TX5514 ({Delta}ebpR). The numbers below the x axis correspond to the five independent cultures used for this assay. (B) pTCV-PebpR::lacZ in OG1RF and in TX5514 streaked onto TSBG plates containing 10 µg of erythromycin/ml and 200 µg of X-Gal (5-bromo-4-chloro-3-indolyl-ß-D-galactopyranoside)/ml and incubated for 48 h at 37°C. The negative control plasmid is pTCV-lacZ, and the positive control is pTEX5269. The ß-galactosidase assay results (expressed as the optical density at 420 nm/mg of protein/ml) located under the spots correspond to a representative experiment performed with samples collected at entry into the stationary growth phase of cultures grown in TSBG (performed in triplicate).

To begin examining how epbR is regulated, we mapped the transcriptional start site of OG1RF. Using the RACE (for rapid amplification of cDNA ends) kit, only one start site for ebpR was found at –21 bp. Looking at the promoter area, no canonical –10 and –35 bp sequences were detected, indicating that the expression of ebpR is likely sigma A independent. We next looked at possible ebpR autoregulation by inserting a 301-bp fragment overlapping the entire 209-bp region separating ebpA from ebpR into pTCV-lacZ to create a transcriptional lacZ fusion. The ß-galactosidase activity of this construct in an ebpR background compared to the wild type was measured (6). No ß-galactosidase activity was detected using the PebpR::lacZ fusion in the ebpR mutant, whereas it was detectable in the wild type (Fig. 1B). The results indicate that ebpR is autoactivated.

In addition to examining transcript levels, we examined pilus production in the wild type (OG1RF), the {Delta}ebpR mutant (TX5514), and a complemented strain (TX5582) in which ebpR was cloned under the control of the nisin promoter in pMSP3535 (3). As determined by RT-PCR, the expression of ebpR in TX5582 was detected even without nisin (data not shown). In order to detect the pili, mutanolysin extracts were made from OG1RF as described previously (13). As seen before, a ladder profile was detected using antibodies to EbpA (Fig. 2, lane 1). It was not observed in extracts from the ebpR mutant (lane 2) or in extracts from the mutant carrying the empty vector (lane 3). However, it was detected in the complemented strain (Fig. 2, lane 4). A similar result was observed using EbpC antibodies (data not shown).


Figure 2
View larger version (79K):
[in this window]
[in a new window]

  		FIG. 2. Western blots of OG1RF and its {Delta}ebpR mutant (TX5514). Mutanolysin surface extract preparations were probed with anti-EbpA rabbit polyclonal immune serum. Lanes: 1, OG1RF; 2, {Delta}ebpR mutant (TX5514); 3, {Delta}ebpR(pMSP3535) (TX5584); 4, {Delta}ebpR(pTEX5515) (TX5582); 5, EbpA recombinant protein with a molecular mass of 113 kDa.

Nallapareddy et al. reported that only 10 to 20% of OG1RF cells had observable pili by electron microscopy (13). To evaluate this observation using another methodology, intact bacteria fixed with 4.4% (wt/vol) paraformaldehyde were probed with anti-EbpA or anti-EbpC rabbit antibodies by indirect immunofluorescence. Binding of anti-EbpA or anti-EbpC antibodies to the surface-exposed epitopes were detected using fluorescein isothiocyanate (FITC)-labeled anti-rabbit antibodies (Sigma, St. Louis, MO). First, we tested OG1RF and the ebpA deletion mutant for the presence of pili in cells grown in TSBG and collected in stationary phase. Using anti-EbpA, FITC-labeled cells were detected in the OG1RF population (Fig. 3A) but not in the ebpA mutant population. The fluorescence was present on the entire surface of the cells except at the septum. Since EbpA was shown to be expressed and detectable as a monomer by Western blotting in ebpB and ebpC insertion mutants (13), these two strains were also assessed by immunofluorescence. As shown in Fig. 3A, a fluorescent dot (marked by an arrow and shown at a higher resolution in the insert) was visible on a few of the ebpB insertion mutant cells, whereas no fluorescence was detected at the surface of the ebpC insertion mutant. In a subsequent experiment, OG1RF, the ebpR deletion mutant, and the complemented strain were grown under the same conditions (TSBG, stationary phase, no nisin induction). In the OG1RF population, 15% of the cells were labeled with FITC, whereas no fluorescence was detected on the surface of the ebpR mutant cells (Fig. 3B). With the complemented strain, 17% of the population was FITC labeled (Fig. 3B, boxed numbers). We can postulate that ebpR and/or ebpABC are influenced by and/or may influence other regulatory pathways, since even in the presence of a functional ebpR, the majority of the cells are not producing pili at their surfaces. However, when cloned ebpR was transferred into the wild type, the level of FITC-labeled cells increased to 70% (preliminary data), whereas only 17% were labeled when the same plasmid was introduced into the {Delta}ebpR strain. These results indicate that the level of ebpR expression affects ebpABC expression or that the presence of the plasmid is titrating out a negative regulator.


Figure 3
View larger version (87K):
[in this window]
[in a new window]

  		FIG. 3. Immunofluorescence analysis showing surface localization of EbpA. Cells were collected at stationary growth phase from a TSBG culture and assayed using anti-EbpA rabbit serum. The left panel is the phase-contrast image of the field visualized with the FITC filter (right panel). (A) Parental OG1RF. TX5475 is the {Delta}ebpA mutant, TX5460 is the {triangledown}ebpB mutant ({triangledown}, insertion mutant), and TX5448 is the {triangledown}ebpC mutant. The area indicated with an arrow is shown in a box as an overlay between phase contrast and FITC visualization. (B) Parental OG1RF. TX5514 is the {Delta}ebpR mutant; the {Delta}ebpR mutant electroporated with vector only (pMSP3535) served as a control. The {Delta}ebpR mutant electroporated with pMSP3535::ebpR is the complemented strain. The boxed numbers correspond to the percentage of FITC-labeled cells from at least 250 cells counted. Bar, 10 µm.

Strains containing mutations in the ebpABC operon were previously shown to have reduced biofilm formation (13). Since the ebpR mutant displays greatly reduced expression of the ebpABC operon, it was also predicted to be defective in biofilm formation. Biofilm formation and adherence to a polystyrene surface were assessed quantitatively as described previously (10). As shown in Table 2, the ebpR mutant displayed a significant reduction in biofilm formation (47% reduction, P < 0.01) (Table 2). Of interest, the complemented strain presented a statistically significant increase in biofilm formation compared to OG1RF (22% more biofilm formation, P < 0.01). The biofilm defect in the ebpA and ebpR mutants was consistent with reductions in primary adherence of 43 and 64% at 30 min and 53 and 69% reduction at 2 h, respectively (P < 0.01) (Table 2).


View this table:
[in this window]
[in a new window]

  		TABLE 2. Biofilm and primary adherence assays

In vivo, it has been shown that the ebpA mutant was significantly attenuated in the rat endocarditis model (13) and the murine urinary tract infection model (17). We attempted to quantify gene expression in vivo by using the rat endocarditis model. Preliminary data from vegetations collected at 48 h indicate that ebpA expression was 100 times lower in the ebpR deletion mutant, whereas srtC expression was not appreciably affected (preliminary results, data not shown). This experiment demonstrates the feasibility of detecting and quantifying gene expression in the rat endocarditis model, opening new avenues for research directed at understanding bacterial endocarditis.

In conclusion, we identified an E. faecalis transcriptional regulator, EbpR, which positively affects the expression of the endocarditis-associated pilus operon, thereby influencing biofilm formation. It will be of interest in future studies to address the signals to which ebpR is responding and whether these signals affect pilus production both in vitro and in vivo.


arrow
ACKNOWLEDGMENTS
 
We are grateful to L. C. Thomson and P. Bruscella for technical assistance and T. M. Koehler and S. R. Nallapareddy for helpful discussion.

This study was supported by grant NIH R37 AI47923 from the Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Disease, to B.E.M. and by a new scholar award in global infectious disease to D.A.G. from the Ellison medical Foundation.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Division of Infectious Diseases, Center for the Study of Emerging and Re-emerging Pathogens, MSB 2.112, University of Texas Medical School, 6431 Fannin St., Houston, TX 77030. Phone: (713) 500-6745. Fax: (713) 500-6766. E-mail: BEM.asst{at}uth.tmc.edu Back

{triangledown} Published ahead of print on 22 June 2007. Back


arrow
REFERENCES
 
    1
  1. Aakra, A., H. Vebo, L. Snipen, H. Hirt, A. Aastveit, V. Kapur, G. M. Dunny, B. E. Murray, and I. F. Nes. 2005. Transcriptional response of Enterococcus faecalis V583 to erythromycin. Antimicrob. Agents Chemother. 49:2246-2259.[Abstract/Free Full Text]
    2. 2
  2. Bourgogne, A., S. G. Hilsenbeck, G. M. Dunny, and B. E. Murray. 2006. Comparison of OG1RF and an isogenic fsrB deletion mutant by transcriptional analysis: the Fsr system of Enterococcus faecalis is more than the activator of gelatinase and serine protease. J. Bacteriol. 188:2875-2884.[Abstract/Free Full Text]
    3. 3
  3. Bryan, E. M., T. Bae, M. Kleerebezem, and G. M. Dunny. 2000. Improved vectors for nisin-controlled expression in gram-positive bacteria. Plasmid 44:183-190.[CrossRef][Medline]
    4. 4
  4. Drysdale, M., A. Bourgogne, S. G. Hilsenbeck, and T. M. Koehler. 2004. atxA controls Bacillus anthracis capsule synthesis via acpA and a newly discovered regulator, acpB. J. Bacteriol. 186:307-315.[Abstract/Free Full Text]
    5. 5
  5. Garsin, D. A., J. Urbach, J. C. Huguet-Tapia, J. E. Peters, and F. M. Ausubel. 2004. Construction of an Enterococcus faecalis Tn917-mediated gene disruption library offers insight into Tn917 insertion patterns. J. Bacteriol. 186:7280-7289.[Abstract/Free Full Text]
    6. 6
  6. Hancock, L. E., B. D. Shepard, and M. S. Gilmore. 2003. Molecular analysis of the Enterococcus faecalis serotype 2 polysaccharide determinant. J. Bacteriol. 185:4393-4401.[Abstract/Free Full Text]
    7. 7
  7. Kristich, C. J., J. R. Chandler, and G. M. Dunny. 2007. Development of a host-genotype-independent counterselectable marker and a high-frequency conjugative delivery system and their use in genetic analysis of Enterococcus faecalis. Plasmid 57:131-144.[CrossRef][Medline]
    8. 8
  8. Leenhouts, K., G. Buist, A. Bolhuis, A. ten Berge, J. Kiel, I. Mierau, M. Dabrowska, G. Venema, and J. Kok. 1996. A general system for generating unlabeled gene replacements in bacterial chromosomes. Mol. Gen. Genet. 253:217-224.[CrossRef][Medline]
    9. 9
  9. Malani, P. N., C. A. Kauffman, and M. J. Zervos. 2002. Enterococcal disease, epidemiology, and treatment, p. 385-408. In M. S. Gilmore, D. B. Clewell, P. Courvalin, G. M. Dunny, B. E. Murray, and L. B. Rice (ed.), The enterococci: pathogenesis, molecular biology, and antibiotic resistance. ASM Press, Washington, DC.
    10. 10
  10. Mohamed, J. A., W. Huang, S. R. Nallapareddy, F. Teng, and B. E. Murray. 2004. Influence of origin of isolates, especially endocarditis isolates, and various genes on biofilm formation by Enterococcus faecalis. Infect. Immun. 72:3658-3663.[Abstract/Free Full Text]
    11. 11
  11. Murray, B. E., K. V. Singh, R. P. Ross, J. D. Heath, G. M. Dunny, and G. M. Weinstock. 1993. Generation of restriction map of Enterococcus faecalis OG1 and investigation of growth requirements and regions encoding biosynthetic function. J. Bacteriol. 175:5216-5223.[Abstract/Free Full Text]
    12. 12
  12. Nallapareddy, S. R., and B. E. Murray. 2006. Ligand-signaled upregulation of Enterococcus faecalis ace transcription, a mechanism for modulating host-E. faecalis interaction. Infect. Immun. 74:4982-4989.[Abstract/Free Full Text]
    13. 13
  13. Nallapareddy, S. R., K. V. Singh, J. Sillanpaa, D. A. Garsin, M. Hook, S. L. Erlandsen, and B. E. Murray. 2006. Endocarditis and biofilm-associated pili of Enterococcus faecalis. J. Clin. Investig. 116:2799-2807.[CrossRef][Medline]
    14. 14
  14. Poyart, C., and P. Trieu-Cuot. 1997. A broad-host-range mobilizable shuttle vector for the construction of transcriptional fusions to beta-galactosidase in gram-positive bacteria. FEMS Microbiol. Lett. 156:193-198.[Medline]
    15. 15
  15. Qin, X., K. V. Singh, G. M. Weinstock, and B. E. Murray. 2000. Effects of Enterococcus faecalis fsr genes on production of gelatinase and a serine protease and virulence. Infect. Immun. 68:2579-2586.[Abstract/Free Full Text]
    16. 16
  16. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
    17. 17
  17. Singh, K. V., S. R. Nallapareddy, and B. E. Murray. 2007. Importance of the ebp (endocarditis- and biofilm-associated pilus) locus in the pathogenesis of Enterococcus faecalis ascending urinary tract infection. J. Infect. Dis. 195:1671-1677.[CrossRef][Medline]

Journal of Bacteriology, September 2007, p. 6490-6493, Vol. 189, No. 17
0021-9193/07/$08.00+0     doi:10.1128/JB.00594-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Guiton, P. S., Hung, C. S., Kline, K. A., Roth, R., Kau, A. L., Hayes, E., Heuser, J., Dodson, K. W., Caparon, M. G., Hultgren, S. J. (2009). Contribution of Autolysin and Sortase A during Enterococcus faecalis DNA-Dependent Biofilm Development. Infect. Immun. 77: 3626-3638 [Abstract] [Full Text]  
  • Teng, F., Singh, K. V., Bourgogne, A., Zeng, J., Murray, B. E. (2009). Further Characterization of the epa Gene Cluster and Epa Polysaccharides of Enterococcus faecalis. Infect. Immun. 77: 3759-3767 [Abstract] [Full Text]  
  • Ballering, K. S., Kristich, C. J., Grindle, S. M., Oromendia, A., Beattie, D. T., Dunny, G. M. (2009). Functional Genomics of Enterococcus faecalis: Multiple Novel Genetic Determinants for Biofilm Formation in the Core Genome. J. Bacteriol. 191: 2806-2814 [Abstract] [Full Text]  
  • Coburn, P. S., Baghdayan, A. S., Dolan, G., Shankar, N. (2008). An AraC-Type Transcriptional Regulator Encoded on the Enterococcus faecalis Pathogenicity Island Contributes to Pathogenesis and Intracellular Macrophage Survival. Infect. Immun. 76: 5668-5676 [Abstract] [Full Text]  
  • Kristich, C. J., Nguyen, V. T., Le, T., Barnes, A. M. T., Grindle, S., Dunny, G. M. (2008). Development and Use of an Efficient System for Random mariner Transposon Mutagenesis To Identify Novel Genetic Determinants of Biofilm Formation in the Core Enterococcus faecalis Genome. Appl. Environ. Microbiol. 74: 3377-3386 [Abstract] [Full Text]  
  • Mohamed, J. A., Huang, D. B. (2007). Biofilm formation by enterococci. J Med Microbiol 56: 1581-1588 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bourgogne, A.
Right arrow Articles by Garsin, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bourgogne, A.
Right arrow Articles by Garsin, D. A.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»